Baby Safety / Compounds / Psilocin (4-HO-DMT)

Is Psilocin (4-HO-DMT) safe for babies and kids?

Very high risk for kids

Infants are more vulnerable to Psilocin (4-HO-DMT) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is psilocin (4-ho-dmt)?

The IUPAC name is [3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] dihydrogen phosphate.

Also known as: Psilocybine, Psilocybin, Indocybin, Psilocibin.

IUPAC name
[3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] dihydrogen phosphate
CAS number
520-53-6
Molecular formula
C12H17N2O4P
Molecular weight
284.25 g/mol
SMILES
CN(C)CCc1c[nH]c2cccc(O)c12
PubChem CID
10624

Risk for babies

Very high risk

Infants are more vulnerable to Psilocin (4-HO-DMT) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Psilocin (4-HO-DMT), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

2 regulatory and scientific bodies have classified Psilocin (4-HO-DMT). The classifications differ — that's the data.

AgencyYearClassificationNotes
DEA1970Schedule I controlled substance
FDA2018Breakthrough Therapy designation (as psilocybin prodrug) for treatment-resistant depression

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter psilocin (4-ho-dmt)

  • Natural Product
  • Research Chemical

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Psilocin (4-HO-DMT):

  • Ketamine/esketamine (FDA-approved)
    Trade-offs: Different mechanism. Shorter duration. Dissociative not psychedelic. FDA-approved.
    Relative cost: $600-900/session

Frequently asked questions

Is psilocin (4-ho-dmt) safe for kids?

Infants are more vulnerable to Psilocin (4-HO-DMT) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What should I do if my child is exposed to psilocin (4-ho-dmt)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

See Psilocin (4-HO-DMT) in the baby app

Look up products containing psilocin (4-ho-dmt), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →